Microvision Inc (MVIS)
Official siteTECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ
Market Cap: $35.07M
Last updated: Nov 17, 2026 at 4:32 PM ET
Microvision Inc (MVIS) Statistics
Microvision (MVIS) has a market cap of $35.07M and an enterprise value of $28.79M. It kept -2230.59% of revenue as net income over the last 12 months. Its share count is up 39.05% from a year earlier.
Total Valuation
Enterprise value is 17.91% below the market cap, as cash exceeds debt.
| Market Cap | $35.07M |
|---|---|
| Enterprise Value | $28.79M |
| Latest price (Nov 17, 2026) | $0.97 |
Key Dates
The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 28, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.3x and 1.2x. Its year-end P/S ranged from 46.1x to 877.8x from 2016 to 2024.
| P/S Ratio | 5.3x |
|---|---|
| P/B Ratio | 1.2x |
| P/TBV Ratio | 4.6x |
Price Statistics
The stock is down 92.96% over 52 weeks and trades 28.15% below its 50-day average.
| Beta (1Y) | 2.55 |
|---|---|
| 52-Week Change | -92.96% |
| 1-Month Change | -19.52% |
| 3-Month Change | -45.44% |
| 6-Month Change | -88.60% |
| 5-Year Change | -98.82% |
| 10-Year Change | -91.17% |
| Total Return (1Y) | -92.96% |
| Total Return (3Y CAGR) | -70.18% |
| Total Return (5Y CAGR) | -61.97% |
| Max Drawdown (1Y) | -93.55% |
| Max Drawdown (3Y) | -97.68% |
| Sharpe Ratio (1Y) | -2.29 |
| Correlation with SPY (1Y) | 0.30 |
| 50-Day Average | $1.35 |
| 200-Day Average | $5.82 |
| 52-Week Range | $0.98 to $16.05 |
| RSI (14 Days) | 32.4 |
| Average Volume (20 Days) | 992.46K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.80x current liabilities, and total debt is 0.99x shareholder equity.
| Current Ratio | 0.80x |
|---|---|
| Quick Ratio | 0.71x |
| Debt / Equity | 0.99x |
| Interest Coverage | -6.75x |
Returns and Efficiency
Return on invested capital is -215.50% over the last 12 months, against a 5-year average of -92.83%.
| Return on Equity (ROE) | -493.37% |
|---|---|
| Return on Assets (ROA) | -123.55% |
| Return on Invested Capital (ROIC) | -215.50% |
| Return on Capital Employed (ROCE) | -223.76% |
| ROA (5Y Average) | -63.07% |
| ROIC (5Y Average) | -92.83% |
| Asset Turnover | 0.04x |
| Inventory Turnover | 4.70x |
| Receivables Turnover | 4.34x |
| Cash Conversion Cycle | 44 days |
Scores
MVIS has an Altman Z-Score of -19.29, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -19.29 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $5.03M over the last 12 months is up 90.93% from the 12 months before.
| Revenue | $5.03M |
|---|---|
| Revenue Growth (YoY) | +90.93% |
| Gross Profit | -$13.90M |
| Operating Income | -$110.45M |
| Pretax Income | -$112.25M |
| Net Income | -$112.22M |
| EBITDA | -$76.66M |
| EBIT | -$97.76M |
| Reported EPS (TTM) | -$2.24 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 25.05% of the $90.83M in total assets.
| Cash and Equivalents | $28.89M |
|---|---|
| Total Debt | $22.61M |
| Net Cash | $6.28M |
| Net Cash Per Share | $0.23 |
| Working Capital | -$9.29M |
| Shareholder Equity | $22.75M |
| Book Value Per Share | $0.83 |
| Tangible Book Value | $5.71M |
| Tangible Book Per Share | $0.21 |
| Total Assets | $90.83M |
| Total Liabilities | $68.08M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.06M of capital spending, operating cash flow left -$66.69M of free cash flow.
| Operating Cash Flow | -$64.63M |
|---|---|
| Capital Expenditures | $2.06M |
| Free Cash Flow | -$66.69M |
| FCF Per Share | -$2.18 |
| Depreciation and Amortization | $21.11M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2195.45%.
| Gross Margin | -276.25% |
|---|---|
| Operating Margin | -2195.45% |
| Pretax Margin | -2231.11% |
| Net Margin | -2230.59% |
| EBITDA Margin | -1523.71% |
| EBIT Margin | -1943.21% |
| FCF Margin | -1325.54% |
Growth
Revenue grew 22.08% a year over 3 years.
| Revenue Growth (3Y CAGR) | +22.08% |
|---|---|
| Revenue Growth (5Y CAGR) | -17.13% |
| Book Value Per Share Growth (2Y CAGR) | -39.85% |
| Tangible Book Per Share Growth (2Y CAGR) | -33.59% |
Dividends and Yields
MVIS does not pay a dividend. Its free cash flow yield is -252.12%.
| FCF Yield | -252.12% |
|---|---|
| Buyback Yield | -81.10% |
| Shareholder Yield | -81.10% |
Stock Splits
The last split was a 1-for-15 reverse split on Aug 3, 2026.
| Last Split Date | Aug 3, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 12 similar companies, MVIS has the 4th highest P/S.
P/S RatioPeer median 2.5x
ROICPeer median -12.42%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +16.50%
| P/S Ratio | 5.3x vs 2.5x median |
|---|---|
| ROIC | -215.50% vs -12.42% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +90.93% vs +16.50% median |
Analyst Forecast
Consensus estimates put revenue growth at 306.89% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +306.89% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MVIS
What is MVIS's market cap?
Microvision has a market cap of $35.07M. Its enterprise value, which adds debt and subtracts cash, is $28.79M.
How many shares of MVIS are outstanding?
Microvision has 27.39M shares outstanding. The count is up 39.05% from a year earlier.
Does MVIS pay a dividend?
No. Microvision does not pay a dividend.
How much debt does MVIS have?
Microvision has $22.61M of total debt and $28.89M of cash and equivalents, a net cash position of $6.28M.
MVIS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors